Aligos Therapeutics, Inc. - ALGS
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 14
Latest filed: Sep 15, 2026
| Form | Count |
|---|---|
| 4 | 6 |
| 8-K | 5 |
| SCHEDULE 13D | 1 |
| SCHEDULE 13G | 1 |
| SCHEDULE 13G/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Sep 15, 2026 | 8-K | Sep 10, 2026 | 0001193125-26-391880 | View |
| Aug 06, 2026 | 8-K | Aug 06, 2026 | 0001171843-26-005294 | View |
| Jun 29, 2026 | 4 | Jun 25, 2026 | 0001610717-26-000300 | View |
| Jun 29, 2026 | 4 | Jun 25, 2026 | 0001610717-26-000301 | View |
| Jun 29, 2026 | 4 | Jun 25, 2026 | 0001610717-26-000302 | View |
| Jun 29, 2026 | 4 | Jun 25, 2026 | 0001610717-26-000303 | View |
| Jun 29, 2026 | 4 | Jun 25, 2026 | 0001610717-26-000304 | View |
| Jun 29, 2026 | 4 | Jun 25, 2026 | 0001610717-26-000305 | View |
| Jun 26, 2026 | 8-K | Jun 25, 2026 | 0001193125-26-285426 | View |
| Jun 24, 2026 | SCHEDULE 13D | — | 0001193125-26-281134 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001193125-26-226938 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0000919574-26-003231 | View |
| May 07, 2026 | 8-K | May 07, 2026 | 0001171843-26-003156 | View |
| Apr 21, 2026 | 8-K | Apr 16, 2026 | 0001193125-26-166987 | View |